Boston Scientific BSX · NYSE
$44.39 +0.56% (+$0.25)
Summary
78 / 100 · Bulios Score
What speaks for it
- Earnings per share grew by 63% a year over the last 3 years.
- Out of every 100 USD of revenue, 17 USD is left as net profit.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 17.5 USD for 1 USD of yearly profit. Over the last five years it was 65.6 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 15% a year over 5 years. Over the last 3 years it grew by 17% a year. For the next fiscal year analysts expect revenue to grow by 5.6%. Earnings per share grew by 63% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 29 USD
- Research and development 10 USD
- Sales and administration 39 USD
- Taxes and other 4.0 USD
- Net profit 17 USD
Net profit, industry median (Medical - Devices) 7.0 USD
Out of every 100 USD of revenue, 17 USD is left as net profit.
Profitability in detailIs it financially healthy?
MostlyRepaying all its debt would take 3.5 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 37
- Hold 7
- Sell 0
Today's price within the analysts' price targets
The average target of $64.67 is 46% above today's price. 84% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Cardiovascular 66%
- MedSurg 34%
By region
- UNITED STATES 64%
- Non-US 36%
Cardiovascular brings in 66% of revenue.
Segments in detail